(Sharecast News) - GSK reported a 5% increase in third-quarter sales on Wednesday, driven by strong growth in specialty medicines, as the pharmaceutical giant reaffirmed its full-year guidance.
The FTSE 100 company said turnover rose 4% at actual exchange rates and 5% at constant currencies to £8.89bn.

Core operating profit...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE